Clinical Trial Update: Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion [NA]

View source ↗

Summary

A clinical trial is evaluating whether the Composite WM Formula can promote GLP-1 secretion to treat obesity. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Composite WM Formula

Snippet

Sponsor: TCI Co., Ltd. | Conditions: Obesity | NA | Status: NOT_YET_RECRUITING